ZeClinics

Barcelona, Spain Founded: 2013 • Age: 13 yrs
Zebrafish models for toxicity studies are developed by ZeClinics CRO.
Annual revenue - Latest available
Total funding - 7 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About ZeClinics

ZeClinics is a company based in Barcelona (Spain) founded in 2013. ZeClinics operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

  • Headquarter Barcelona, Spain
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $108.22 K (USD), Grant

    Oct 01, 2022

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ZeClinics

Investors in ZeClinics

ZeClinics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Locked Locked Locked
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for ZeClinics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ZeClinics

Investments
Premium access

Investment portfolio details for ZeClinics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ZeClinics

Premium access

Detailed financials for ZeClinics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Zeclinics Comparisons

ZeClinics Primary company
Description
Zebrafish models for toxicity studies are developed by ZeCli...
Location
Barcelona, Spain
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ZeClinics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ZeClinics

ZeClinics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Humanized mouse models are developed for preclinical immune drug studies.
Locked Locked Locked
Provider of transgenic rodent models and customized cell lines for preclinical development
Locked Locked Locked
Preclinical CRO services for CNS and orphan disorders are offered.
Locked Locked Locked
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
Locked Locked Locked
Animal models are supplied for in-vivo analytical services.
Locked Locked Locked
Preclinical contract research organization offering standard GLP and non-GLP services
Premium access

Detailed competitors of ZeClinics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Zeclinics

Premium access

Complete news archive for ZeClinics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ZeClinics

ZeClinics was founded in 2013 and raised its 1st funding round 4 years after it was founded.

ZeClinics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

ZeClinics was founded in 2013 and is based in Barcelona, Spain, where support from University Pompeu Fabra and incubation at Barcelona Biomedicine Research Park are provided. Operations focus on contract research organization services in the biotech sector, including toxicity, efficacy, and genesis assays conducted on zebrafish with CRISPRCas9 technology. Proprietary models developed by the company have been licensed to institutions such as Harvard, MIT, and the Broad Institute.

ZeClinics's top competitors include GenOway, PsychoGenics and Alpha Genesis.

ZeClinics has 2 investors. Key investors include European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available